To investigate the significance of impaired insulin secretion on preim
plantation embryo development, outbred ICR female mice received a sing
le injection of streptozotocin 130 mg (low) and 160 mg (subdiabetic) k
g(-1), 14-17 days before fertilization. Preimplantation embryos were c
ollected on day 3 of pregnancy, four to eight-cell embryos were cultur
ed in vitro 48 h (day 5) and their cell number was estimated. After sp
ontaneous ovulation, the significantly different distribution pattern
in comparison with the controls was detected only in preimplantation e
mbryos isolated from subdiabetic (160 mg.kg(-1) streptozotocin) mice.
Furthermore, the incidence of degenerated embryos was significantly in
creased after 48 h in vitro cultivation. The analysis of cell number d
istribution in embryos after cultivation irt vitro indicated a signifi
cant delay in cell proliferation in both experimental groups (130 and
160 mg.kg(-1) streptozotocin) in comparison with control mice. After s
uperovulation, the only significant difference was found in the distri
bution pattern of embryos isolated on day 3 of pregnancy from subdiabe
tic (160 mg.kg(-1) streptozotocin) mice. No significant differences we
re found after embryo cultivation in vitro. It could be concluded that
, in outbred ICR mice, lower streptozotocin treatment (130 mg.kg(-1))
influenced only cell distribution of in vitro cultured embryos after s
pontaneous ovulation. In ICR mice, marked changes in preimplantation e
mbryo development were detected only after subdiabetic (160 mg.kg(-1))
streptozotocin treatment. During in vitro cultivation delayed effects
of impaired insulin secretion resulted in an increase of embryo degen
eration at the time after the third mitotic cleavage. Our results indi
cate that the effects of impaired maternal insulin secretion on preimp
lantation embryo development in mice are marked and consistent after s
pontaneous ovulation. Superovulation apparently disguises subtle chang
es in preimplantation embryo development after low and subdiabetic str
eptozotocin treatment.